Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

746
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
746
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

922
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
922
Atypical Pneumonia01:14

Atypical Pneumonia

62
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAPK12 Upregulates PD-L1 Expression in Hepatocellular Carcinoma to Induce Immune Suppression Through the PI3K/AKT/mTOR Pathway.

Journal of biochemical and molecular toxicology·2026
Same author

Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

Signal transduction and targeted therapy·2026
Same author

Pathological mechanisms of osteoarthritis in the network of geriatric comorbidities: Emerging insights from organs-crosstalk.

Journal of orthopaedic translation·2026
Same author

A systematic review of artificial intelligence-based diagnosis models for idiopathic pulmonary fibrosis.

Journal of thoracic disease·2026
Same author

Iodination of Arenes Driven by Hypervalent Iodine-Based Halogen Bonding: Compatible with Electron-Deficient Arenes.

The Journal of organic chemistry·2026
Same author

A Scalable Polymer Multilayer Film Strategy for Colored Photovoltaics with Passive Thermal Management and Data-Driven Multiphysics Design.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Apr 14, 2026

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

1.6K

Nontuberculous mycobacterial osteomyelitis.

Sheng Bi1, Fei-Shu Hu, Hai-Ying Yu

  • 1From the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University , Hangzhou , China.

Infectious Diseases (London, England)
|April 28, 2015
PubMed
Summary

Nontuberculous mycobacteria (NTM) osteomyelitis is a severe bone infection requiring prompt diagnosis and long-term treatment. Early detection and appropriate antibiotic therapy are crucial for managing this challenging condition, especially in immunocompromised patients.

Keywords:
Osteomyelitisdiabetes mellitusnontuberculous mycobacteria

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Related Experiment Videos

Last Updated: Apr 14, 2026

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

1.6K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Area of Science:

  • Infectious Diseases
  • Orthopedics
  • Immunology

Background:

  • Osteomyelitis caused by nontuberculous mycobacteria (NTM) presents significant challenges due to severe consequences and poor prognosis.
  • Pathogenesis is linked to immune defects, including the interleukin-12-interferon-γ-tumor necrosis factor-α axis, HIV infection, immunosuppression, and diabetes mellitus.

Purpose of the Study:

  • To highlight the importance of physician awareness regarding NTM osteomyelitis, particularly in immunocompromised individuals.
  • To outline diagnostic and therapeutic strategies for NTM osteomyelitis.

Main Methods:

  • Diagnosis relies on culture and species identification from tissue biopsies or surgical debridement.
  • Imaging examinations are essential for diagnosis and monitoring.
  • In vitro drug susceptibility testing guides antibiotic selection.

Main Results:

  • Effective treatment involves adequate surgical debridement and long-term combination antibiotic therapy.
  • Monitoring for side effects during prolonged treatment is critical.
  • Adequate chemotherapy duration and regular patient monitoring are key to recovery.

Conclusions:

  • NTM osteomyelitis requires vigilant clinical suspicion and a comprehensive management approach.
  • Multidrug, long-term chemotherapy with close monitoring is essential for successful outcomes.
  • Integrated care combining surgical intervention, targeted antibiotics, and vigilant follow-up improves patient prognosis.